- Home
- NLSP vs CHNR Comparison
NLSP vs CHNR Comparison
Compare NLSP & CHNR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NLSP
- CHNR
- Stock Information
- Founded
- NLSP 2015
- CHNR N/A
- Country
- NLSP Switzerland
- CHNR China
- Employees
- NLSP N/A
- CHNR N/A
- Industry
- NLSP Biotechnology: Pharmaceutical Preparations
- CHNR Precious Metals
- Sector
- NLSP Health Care
- CHNR Basic Materials
- Exchange
- NLSP Nasdaq
- CHNR Nasdaq
- Market Cap
- NLSP 12.4M
- CHNR 4.6M
- IPO Year
- NLSP 2021
- CHNR 1995
- Fundamental
- Price
- NLSP $2.10
- CHNR $3.68
- Analyst Decision
- NLSP
- CHNR
- Analyst Count
- NLSP 0
- CHNR 0
- Target Price
- NLSP N/A
- CHNR N/A
- AVG Volume (30 Days)
- NLSP 275.3K
- CHNR 37.8K
- Earning Date
- NLSP 07-22-2025
- CHNR 05-15-2025
- Dividend Yield
- NLSP N/A
- CHNR N/A
- EPS Growth
- NLSP N/A
- CHNR N/A
- EPS
- NLSP N/A
- CHNR N/A
- Revenue
- NLSP N/A
- CHNR N/A
- Revenue This Year
- NLSP N/A
- CHNR N/A
- Revenue Next Year
- NLSP N/A
- CHNR N/A
- P/E Ratio
- NLSP N/A
- CHNR N/A
- Revenue Growth
- NLSP N/A
- CHNR N/A
- 52 Week Low
- NLSP $1.30
- CHNR $3.35
- 52 Week High
- NLSP $15.59
- CHNR $9.04
- Technical
- Relative Strength Index (RSI)
- NLSP 46.61
- CHNR 43.59
- Support Level
- NLSP $2.20
- CHNR $3.35
- Resistance Level
- NLSP $3.08
- CHNR $3.71
- Average True Range (ATR)
- NLSP 0.25
- CHNR 0.30
- MACD
- NLSP -0.06
- CHNR -0.03
- Stochastic Oscillator
- NLSP 8.40
- CHNR 29.41
About NLSP NLS Pharmaceutics Ltd.
NLS Pharmaceutics Ltd a clinical-stage biopharmaceutical company focused on the discovery and development of inventive therapies for patients with rare and complex CNS disorders with unmet medical needs. Its compound, mazindol, a triple monoamine reuptake inhibitor and partial orexin receptor 2 agonist, in a proprietary ER formulation, is being developed for the treatment of narcolepsy, IH (follow-on indication), and potentially ADHD (back-up indication). Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.
About CHNR China Natural Resources Inc.
China Natural Resources Inc is engaged in exploration for lead, silver, and other metals in the Inner Mongolia Autonomous Region of the PRC and exploration of attractive opportunities in other sectors. The company has a single operating segment: exploration and mining.